Phenotypic screening in drug discovery has long been revived with the expectation of delivering promising lead compounds and drug targets and improving the accomplishment price of drug acceptance. Nevertheless, target identification stays A significant bottleneck in phenotype-primarily based drug discovery. We identified the lead compounds K542 and K405 which has https://garryw110lwg3.ja-blog.com/profile